{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:10:15Z","timestamp":1782997815393,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Myeloid-derived suppressor cells (MDSCs) are a population of myeloid progenitor cells with immunoregulatory functions and their role in myasthenia gravis (MG) was unknown. In this study, we investigated the phenotypic and functional alterations of MDSCs in MG before and after immunotherapy. The frequency of MDSCs significantly increased and negatively correlated to that of Th1 or Th17 cells after immunotherapy. MDSCs from untreated patients with MG showed an impaired suppression of IFN-\u03b3 production in T-cells and improved immunosuppressive function was identified after immunotherapy. The MFI of Arg-1 in MDSCs also increased after immunotherapy. These findings suggested the functional difference in MDSCs before and after immunotherapy, and MDSCs might play a role in disease remission.<\/jats:p>","DOI":"10.3389\/fneur.2022.902384","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:29:02Z","timestamp":1656480542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.autrev.2017.03.011","article-title":"Regulatory Immune cells and functions in autoimmunity and transplantation immunology","volume":"16","author":"Papp","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clim.2017.03.003","article-title":"Cd4(+) Foxp3(+) T regulatory cell subsets in myasthenia gravis patients","volume":"179","author":"Kohler","year":"2017","journal-title":"Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating Cd4(+)Cd25(High)Cd127(Low\/-) T-cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2016.05.004","article-title":"Impaired regulatory B-cells in myasthenia gravis","volume":"297","author":"Sheng","year":"2016","journal-title":"J Neuroimmunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","article-title":"Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through Pd-1-induced Il-10","volume":"193","author":"Huang","year":"2014","journal-title":"J Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4062\/biomolther.2018.201","article-title":"Analysis of the expression and regulation of Pd-1 protein on the surface of Myeloid-derived suppressor cells (Mdscs)","volume":"27","author":"Nam","year":"2019","journal-title":"Biomol Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1007690","DOI":"10.1371\/journal.ppat.1007690","article-title":"Hepatitis B E antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Pathog."},{"key":"B12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.humimm.2016.05.024","article-title":"Myeloid derived suppressor cells and autoimmunity","volume":"77","author":"Boros","year":"2016","journal-title":"Hum Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood-2013-12-546416","article-title":"Cll-cells induce idohi Cd14+Hla-Drlo myeloid-derived suppressor cells that inhibit T-cell Responses and Promote Tregs","volume":"124","author":"Jitschin","year":"2014","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"105581","DOI":"10.1016\/j.tvjl.2020.105581","article-title":"Myeloid-derived suppressor cell and regulatory T-cell frequencies in canine myasthenia gravis: a pilot study","volume":"267","author":"Wu","year":"2021","journal-title":"Vet J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1158\/2326-6066.CIR-13-0129","article-title":"Myeloid-derived suppressor cells in the development of lung cancer","volume":"2","author":"Ortiz","year":"2014","journal-title":"Cancer Immunol Res."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","author":"Veglia","year":"2021","journal-title":"Nat Rev Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13703","DOI":"10.1111\/jcmm.15928","article-title":"Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor beta and S100a8\/9 up-regulation","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1400857","article-title":"Myeloid-derived suppressor cells as a potential therapy for experimental autoimmune myasthenia gravis","volume":"193","author":"Li","year":"2014","journal-title":"J Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.jid.2018.08.023","article-title":"Expansion of Myeloid-derived suppressor cells in the peripheral blood and lesional skin of cutaneous lupus patients","volume":"139","author":"Florez-Pollack","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/imcb.12042","article-title":"Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis","volume":"96","author":"Iacobaeus","year":"2018","journal-title":"Immunol Cell Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/cmi.2017.5","article-title":"Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing Hif1alpha-dependent glycolysis","volume":"15","author":"Lu","year":"2018","journal-title":"cell mol immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fimmu.2018.00282","article-title":"Dexamethasone-induced myeloid-derived suppressor cells prolong allo cardiac graft survival through Inos- and glucocorticoid receptor-dependent mechanism","volume":"9","author":"Zhao","year":"2018","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","article-title":"High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia","volume":"127","author":"Hou","year":"2016","journal-title":"Blood."},{"key":"B27","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fimmu.2019.00900","article-title":"Myeloid-derived suppressor cells in lung transplantation","volume":"10","author":"Heigl","year":"2019","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3389\/fimmu.2020.00643","article-title":"Myeloid-derived suppressor cells in kidney transplant recipients and the effect of maintenance immunotherapy","volume":"11","author":"Iglesias-Escudero","year":"2020","journal-title":"Front Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3389\/fimmu.2019.01202","article-title":"Increased Cd14(+)Hla-Dr(-\/Low) Myeloid-derived suppressor cells correlate with disease severity in systemic lupus erythematosus patients in an Inos-Dependent Manner","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1080\/21691401.2019.1687504","article-title":"The role of myeloid-derived suppressor cells in the pathogenesis of rheumatoid arthritis; anti- or pro-inflammatory cells?","volume":"47","author":"Rajabinejad","year":"2019","journal-title":"Artif Cells Nanomed Biotechnol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.clim.2015.02.001","article-title":"Myeloid-derived suppressor cells are proinflammatory and regulate collagen-induced arthritis through manipulating Th17 Cell differentiation","volume":"157","author":"Zhang","year":"2015","journal-title":"Clin Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3109\/03009742.2012.716450","article-title":"Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis","volume":"42","author":"Jiao","year":"2013","journal-title":"Scand J Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","article-title":"A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces Cd4(+)Cd25(+)Foxp3(+) T Cells","volume":"135","author":"Hoechst","year":"2008","journal-title":"Gastroenterology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","article-title":"Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated Il-17, Ifn-Gamma, and Gm-Csf and Diminished Il-10 Production","volume":"196","author":"Cao","year":"2016","journal-title":"J Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fimmu.2020.00809","article-title":"Cd4(+) T-cells of myasthenia gravis patients are characterized by increased Il-21, Il-4, and Il-17a productions and higher presence of Pd-1 and Icos","volume":"11","author":"Cebi","year":"2020","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"588500","DOI":"10.3389\/fimmu.2020.588500","article-title":"Granulocytic myeloid-derived suppressor cell exosomal prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10+ B Cells","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1002\/art.39767","article-title":"Myeloid-derived suppressor cells induce the expansion of regulatory B-cells and ameliorate autoimmunity in the sanroque mouse model of systemic lupus erythematosus","volume":"68","author":"Park","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI31422","article-title":"Altered macrophage differentiation and immune dysfunction in tumor development","volume":"117","author":"Sica","year":"2007","journal-title":"J Clin Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1182\/blood-2006-06-031856","article-title":"L-arginine availability regulates T-lymphocyte cell-cycle progression","volume":"109","author":"Rodriguez","year":"2007","journal-title":"Blood."},{"key":"B41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00432-009-0634-0","article-title":"Population alterations of L-arginase- and inducible nitric oxide synthase-expressed Cd11b+\/Cd14(-)\/Cd15+\/Cd33+ myeloid-derived suppressor cells and Cd8+ t lymphocytes in patients with advanced-stage non-small cell lung cancer","volume":"136","author":"Liu","year":"2010","journal-title":"J Cancer Res Clin Oncol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.4049\/jimmunol.1801051","article-title":"Increased Gitrl impairs the function of myeloid-derived suppressor cells and exacerbates primary Sjogren syndrome","volume":"202","author":"Tian","year":"2019","journal-title":"J Immunol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.902384\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T05:29:05Z","timestamp":1656480545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.902384\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":42,"alternative-id":["10.3389\/fneur.2022.902384"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2022.902384","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"article-number":"902384"}}